These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 9935200

  • 1. CDK4 gene amplification in osteosarcoma: reciprocal relationship with INK4A gene alterations and mapping of 12q13 amplicons.
    Wei G, Lonardo F, Ueda T, Kim T, Huvos AG, Healey JH, Ladanyi M.
    Int J Cancer; 1999 Jan 18; 80(2):199-204. PubMed ID: 9935200
    [Abstract] [Full Text] [Related]

  • 2. Amplification of the CDK4 gene in sarcomas: tumor specificity and relationship with the RB gene mutation.
    Kanoe H, Nakayama T, Murakami H, Hosaka T, Yamamoto H, Nakashima Y, Tsuboyama T, Nakamura T, Sasaki MS, Toguchida J.
    Anticancer Res; 1998 Jan 18; 18(4A):2317-21. PubMed ID: 9703873
    [Abstract] [Full Text] [Related]

  • 3. Characterization of the 12q15 MDM2 and 12q13-14 CDK4 amplicons and clinical correlations in osteosarcoma.
    Mejia-Guerrero S, Quejada M, Gokgoz N, Gill M, Parkes RK, Wunder JS, Andrulis IL.
    Genes Chromosomes Cancer; 2010 Jun 18; 49(6):518-25. PubMed ID: 20196171
    [Abstract] [Full Text] [Related]

  • 4. CDK4 and MDM2 gene alterations mainly occur in highly proliferative and aggressive mantle cell lymphomas with wild-type INK4a/ARF locus.
    Hernández L, Beà S, Pinyol M, Ott G, Katzenberger T, Rosenwald A, Bosch F, López-Guillermo A, Delabie J, Colomer D, Montserrat E, Campo E.
    Cancer Res; 2005 Mar 15; 65(6):2199-206. PubMed ID: 15781632
    [Abstract] [Full Text] [Related]

  • 5. Amplification and protein expression of chromosome 12q13-15 genes in osteosarcomas of the jaws.
    Lopes MA, Nikitakis NG, Ord RA, Sauk J.
    Oral Oncol; 2001 Oct 15; 37(7):566-71. PubMed ID: 11564577
    [Abstract] [Full Text] [Related]

  • 6. Lack of germ-line mutations of CDK4, p16(INK4A), and p15(INK4B) in families with glioma.
    Gao L, Liu L, van Meyel D, Cairncross G, Forsyth P, Kimmel D, Jenkins RB, Lassam NJ, Hogg D.
    Clin Cancer Res; 1997 Jun 15; 3(6):977-81. PubMed ID: 9815774
    [Abstract] [Full Text] [Related]

  • 7. Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets.
    Reifenberger G, Ichimura K, Reifenberger J, Elkahloun AG, Meltzer PS, Collins VP.
    Cancer Res; 1996 Nov 15; 56(22):5141-5. PubMed ID: 8912848
    [Abstract] [Full Text] [Related]

  • 8. Molecular genetic correlates of p16, cdk4, and pRb immunohistochemistry in glioblastomas.
    Burns KL, Ueki K, Jhung SL, Koh J, Louis DN.
    J Neuropathol Exp Neurol; 1998 Feb 15; 57(2):122-30. PubMed ID: 9600204
    [Abstract] [Full Text] [Related]

  • 9. Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours.
    Dei Tos AP, Doglioni C, Piccinin S, Sciot R, Furlanetto A, Boiocchi M, Dal Cin P, Maestro R, Fletcher CD, Tallini G.
    J Pathol; 2000 Apr 15; 190(5):531-6. PubMed ID: 10727978
    [Abstract] [Full Text] [Related]

  • 10. CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations.
    Nielsen GP, Burns KL, Rosenberg AE, Louis DN.
    Am J Pathol; 1998 Jul 15; 153(1):159-63. PubMed ID: 9665476
    [Abstract] [Full Text] [Related]

  • 11. Amplification pattern of 12q13-q15 genes (MDM2, CDK4, GLI) in urinary bladder cancer.
    Simon R, Struckmann K, Schraml P, Wagner U, Forster T, Moch H, Fijan A, Bruderer J, Wilber K, Mihatsch MJ, Gasser T, Sauter G.
    Oncogene; 2002 Apr 11; 21(16):2476-83. PubMed ID: 11971182
    [Abstract] [Full Text] [Related]

  • 12. MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone.
    Dujardin F, Binh MB, Bouvier C, Gomez-Brouchet A, Larousserie F, Muret Ad, Louis-Brennetot C, Aurias A, Coindre JM, Guillou L, Pedeutour F, Duval H, Collin C, de Pinieux G.
    Mod Pathol; 2011 May 11; 24(5):624-37. PubMed ID: 21336260
    [Abstract] [Full Text] [Related]

  • 13. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course.
    Watanabe T, Katayama Y, Yoshino A, Komine C, Yokoyama T.
    Clin Cancer Res; 2003 Oct 15; 9(13):4884-90. PubMed ID: 14581362
    [Abstract] [Full Text] [Related]

  • 14. Analysis of 12q13-15 genes in parosteal osteosarcoma.
    Gamberi G, Ragazzini P, Benassi MS, Ferrari C, Sollazzo MR, Molendini L, Merli M, Magagnoli G, Ruggieri P, Balladelli A, Orlando C, Bacchini P, Pazzagli M, Picci P.
    Clin Orthop Relat Res; 2000 Aug 15; (377):195-204. PubMed ID: 10943202
    [Abstract] [Full Text] [Related]

  • 15. Molecular analysis of the 9p21 locus and p53 genes in Ewing family tumors.
    López-Guerrero JA, Pellín A, Noguera R, Carda C, Llombart-Bosch A.
    Lab Invest; 2001 Jun 15; 81(6):803-14. PubMed ID: 11406642
    [Abstract] [Full Text] [Related]

  • 16. Deletions of the INK4A gene occur in malignant peripheral nerve sheath tumors but not in neurofibromas.
    Kourea HP, Orlow I, Scheithauer BW, Cordon-Cardo C, Woodruff JM.
    Am J Pathol; 1999 Dec 15; 155(6):1855-60. PubMed ID: 10595915
    [Abstract] [Full Text] [Related]

  • 17. Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma.
    Sonoda Y, Yoshimoto T, Sekiya T.
    Oncogene; 1995 Nov 16; 11(10):2145-9. PubMed ID: 7478535
    [Abstract] [Full Text] [Related]

  • 18. Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas.
    Berner JM, Forus A, Elkahloun A, Meltzer PS, Fodstad O, Myklebost O.
    Genes Chromosomes Cancer; 1996 Dec 16; 17(4):254-9. PubMed ID: 8946207
    [Abstract] [Full Text] [Related]

  • 19. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
    Tannapfel A, Busse C, Weinans L, Benicke M, Katalinic A, Geissler F, Hauss J, Wittekind C.
    Oncogene; 2001 Oct 25; 20(48):7104-9. PubMed ID: 11704835
    [Abstract] [Full Text] [Related]

  • 20. Analysis of cell cycle regulators: p16INK4A, pRb, and CDK4 in low- and high-grade meningiomas.
    Tse JY, Ng HK, Lo KW, Chong EY, Lam PY, Ng EK, Poon WS, Huang DP.
    Hum Pathol; 1998 Nov 25; 29(11):1200-7. PubMed ID: 9824096
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.